Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma.

Osei-Bordom, Daniel C; Sachdeva, Gagandeep; Christou, Niki

Osei-Bordom, Daniel C; Sachdeva, Gagandeep; Christou, Niki.

Afiliación

Osei-Bordom DC; Department of General Surgery, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.
Sachdeva G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Christou N; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastroenterology Research, University of Birmingham, Birmingham, United Kingdom.

Front Med (Lausanne) ; 8: 788869, 2021.

Article en En | MEDLINE | ID: mdl-35096878

Palabras clave

circulating free DNA (cfDNA); circulating free microRNAs; exosomes; liquid biopsy; pancreatic ductal adenocarcinoma; personalized treatment; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google